A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: A Southeastern Cancer Study Group study

Journal of Clinical Oncology

Volumn 10, Issue 7, 1992, Pages 1103-1111

  Vogler, W R ^a   Velez Garcia, E ^a   Weiner, R S ^a   Floum, M A ^a   Bartolucci, A A ^a   Omura, G A ^a   Gerber, M C ^a   Banks, P L C ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYTARABINE; DAUNORUBICIN; IDARUBICIN; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN TOXICITY; SURVIVAL RATE; TOXICITY TESTING;

EID: 0026650021     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1992.10.7.1103     Document Type: Article

References (0)